According to the Prescription Medicines Code of Practice Authority, Pfizer promoted unlicensed medicines and violated a total ...

The CMA delivered a preliminary judgment in the case last year which concluded that Pfizer and Flynn abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to ...

Pfizer has picked up approval in the EU for ... cleared the dual inhibitor (JAK3 and TEC), given as a once-daily oral capsule, to treat people aged 12 and over with the condition, an autoimmune ...

Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.

Pfizer's disclosure Friday that it is ending global development and commercialization efforts for its hemophilia B treatment Beqvez brings an inauspicious ending to a gene therapy that got its ...

Pfizer has teamed up with Summit Therapeutics to assess whether one of the industry’s hottest cancer candidates works well with its antibody-drug conjugates (ADCs). Ivonescimab remains the ...